Maternal Awareness and Attitude about Neonatal Screening Program in the Eastern Region of the Kingdom of Saudi Arabia

2018 ◽  
Vol 70 (2) ◽  
pp. 265-272
Author(s):  
Fadhel Mohammed Alfayez ◽  
Mohammed Ahmed Alamir ◽  
Hassan Ali Alnahwi
Keyword(s):  
Saudi Arabia ◽  
Neonatal Screening ◽  
Screening Program ◽  
Eastern Region ◽  
Kingdom Of Saudi Arabia ◽  
Neonatal Screening Program

scholarly journals Neonatal screening program for five conditions in Honduras

2021 ◽  
Author(s):  
Michelle Melissa Miralda Buckley ◽  
Lindsay Borjas Aguilar ◽  
Rosibel Colindres Lainez ◽  
Hector Joaquin Alvarado Valenzuela ◽  
Fernando Ponce ◽  
...  
Keyword(s):  
Neonatal Screening ◽  
Screening Program ◽  
Neonatal Screening Program

scholarly journals Benign acute childhood myositis in the eastern region of Kingdom of Saudi Arabia; a 5-year experience

2015 ◽  
Vol 10 (2) ◽  
pp. 197-200 ◽  
Author(s):  
Mohammad H. Al-Qahtani ◽  
Abdulelah M. Salih ◽  
Abdullah A. Yousef
Keyword(s):  
Saudi Arabia ◽  
Eastern Region ◽  
Kingdom Of Saudi Arabia

scholarly journals BH4 deficiency identified in a neonatal screening program for hyperphenylalaninemia

2018 ◽  
Vol 94 (2) ◽  
pp. 170-176 ◽  
Author(s):  
Cezar Antonio Abreu de Souza ◽  
Michelle Rosa Andrade Alves ◽  
Rosangelis del Lama Soares ◽  
Viviane de Cássia Kanufre ◽  
Valéria de Melo Rodrigues ◽  
...  
Keyword(s):  
Neonatal Screening ◽  
Screening Program ◽  
Neonatal Screening Program

scholarly journals Ten-year evaluation of a Neonatal Screening Program for Congenital Adrenal Hyperplasia

2014 ◽  
Vol 58 (7) ◽  
pp. 765-771 ◽  
Author(s):  
Marilza Leal Nascimento ◽  
Anísia Nhelety Baptista Cristiano ◽  
Tatiane de Campos ◽  
Masanao Ohira ◽  
Edson Cechinel ◽  
...  
Keyword(s):  
Congenital Adrenal Hyperplasia ◽  
Neonatal Screening ◽  
Screening Program ◽  
Clinical Manifestations ◽  
The State ◽  
Adrenal Hyperplasia ◽  
Santa Catarina ◽  
Salt Wasting ◽  
Neonatal Screening Program ◽  
Treatment Onset

Objective Evaluate the Neonatal Screening Program (NSP) for congenital adrenal hyperplasia (CAH) of the Department of Health of the State of Santa Catarina (Secretaria de Estado da Saúde de Santa Catarina, SES/SC), and provide information to improve the program. Subjects and methods Descriptive, retrospective study of 748,395 children screened between January 2001 and December 2010. We analyzed the coverage of the NSP-SES/SC prevalence of CAH, child’s age when the first sample for 17-hydroxyprogesterone (17OHP) measurement was collected, levels of 17OHP, mean age at treatment onset and main clinical manifestations. Results The NSP-SES/SC covered 89% of the live newborns in the State. It diagnosed 50 cases of CAH, yielding an incidence of 1:14,967. Mean age at collection of the first sample was 7.3 days and mean level of 17OHP was 152.9 ng/mL. The most frequent manifestations were virilized genitalia with nonpalpable gonads, clitoromegaly and genital hyperpigmentation. In three girls, the genre established at birth was incorrect. The salt-wasting form was present in 74% of the cases. There was no occurrence of shock or death. Mean age at treatment onset in the salt-wasting form was 17.4 days compared with 54.9 days in those without the salt-wasting form of the disease. All children were treated with hydrocortisone, and those with salt-wasting CAH were also treated with fludrocortisone. Conclusions The incidence of CAH was 1 case to 14,967 live newborns. Collection of the first sample occurred outside the recommended time, resulting in delays in treatment onset.

scholarly journals The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)

2019 ◽  
Vol 5 (1) ◽  
pp. 11 ◽  
Author(s):  
Ana Silva-Pinto ◽  
Maria Alencar de Queiroz ◽  
Paula Antoniazzo Zamaro ◽  
Miranete Arruda ◽  
Helena Pimentel dos Santos
Keyword(s):  
Sickle Cell Disease ◽  
Sickle Cell ◽  
Health Care Professionals ◽  
Neonatal Screening ◽  
Screening Program ◽  
Cell Disease ◽  
Ministry Of Health ◽  
Basic Care ◽  
Main Challenge ◽  
Neonatal Screening Program

Since 2001, the Brazilian Ministry of Health has been coordinating a National Neonatal Screening Program (NNSP) that now covers all the 26 states and the Federal District of the Brazilian Republic and targets six diseases including sickle cell disease (SCD) and other hemoglobinopathies. In 2005, the program coverage reached 80% of the total live births. Since then, it has oscillated between 80% and 84% globally with disparities from one state to another (>95% in São Paulo State). The Ministry of Health has also published several Guidelines for clinical follow-up and treatment for the diseases comprised by the neonatal screening program. The main challenge was, and still is, to organize the public health network (SUS), from diagnosis and basic care to reference centers in order to provide comprehensive care for patients diagnosed by neonatal screening, especially for SCD patients. Considerable gains have already been achieved, including the implementation of a network within SUS and the addition of scientific and technological progress to treatment protocols. The goals for the care of SCD patients are the intensification of information provided to health care professionals and patients, measures to prevent complications, and care and health promotion, considering these patients in a global and integrated way, to reduce mortality and enhance their quality of life.

Geochemistry and isotopic analysis of brines in the coastal sabkhas, Eastern region, Kingdom of Saudi Arabia

2020 ◽  
Vol 178 ◽  
pp. 104142
Author(s):  
Maaruf Hussain ◽  
Abdulaziz Al-Shaibani ◽  
Khalid Al-Ramadan ◽  
Warren W. Wood
Keyword(s):  
Saudi Arabia ◽  
Isotopic Analysis ◽  
Eastern Region ◽  
Kingdom Of Saudi Arabia

Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program

1990 ◽  
Vol 33 (1) ◽  
pp. 83-84
Author(s):  
D.L. Waters ◽  
S.F.A. Dorney ◽  
K.J. Gaskin ◽  
M.A. Gruca ◽  
M O'Halloran ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Neonatal Screening ◽  
Screening Program ◽  
Pancreatic Function ◽  
Neonatal Screening Program

Results of the first national public breast cancer screening program in the Kingdom of Saudi Arabia

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 1524-1524
Author(s):  
A. Omalkhair ◽  
F. Tahan ◽  
A. Al Naeem ◽  
S. Young ◽  
S. Musaad ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Risk Factors ◽  
Saudi Arabia ◽  
Cancer Screening ◽  
Breast Imaging ◽  
Screening Program ◽  
Pathological Findings ◽  
Kingdom Of Saudi Arabia ◽  
Cancer Screening Program ◽  
Low Incidence

1524 Background: Despite the relatively low incidence in the Kingdom of Saudi Arabia (KSA) compared to Western countries, breast cancer (BC) is the most common cancer among Saudi females for the past 11 consecutive years (National Cancer Registry 1994–2004). The objective of this study is to report the results of the first public national BC screening program in KSA and to evaluate the relationship between imaging and pathological findings and known BC risk factors. Methods: Asymptomatic women 40 years of age or older underwent BC screening at Abdulatif Charitable Cancer Screening Center, Riyadh, KSA. Mammograms were scored using American College of Radiology Breast Imaging Reports and Data System (BIRADS). Correlations between imaging findings and risk factors, as well as pathological findings, were analyzed. Results: A total of 1,215 women were enrolled between September 2007 and April 2008. Median age was 45 years (19–91) and median body mass index (BMI) was 31.6 kg/m2 (16.7–58). A total of 16 cases of cancer were diagnosed (80% are less than stage IIB). No cancer was diagnosed in 942 women with R1/R2 scores and only one case of cancer was diagnosed in 228 women with R0/R3 scores. However, among 26 women with R4/R5 scores, 50% had malignant disease and 35% had benign lesions (odds ratio = 1.96; 95% confidence interval = 1.5, 2.6) (p < 0.0001). No correlation between known risk factors and imaging score or cancer diagnosis. Conclusions: The public acceptance of BC screening program was encouraging. Longitudinal follow-up and inclusion of more participants will help in better determining the risk factors relevant to our patient population. No significant financial relationships to disclose.

Neonatal Screening Program for Congenital Adrenal Hyperplasia: Adjustments to the Recall Protocol

2001 ◽  
Vol 55 (6) ◽  
pp. 271-277 ◽  
Author(s):  
Laura Gruñeiro-Papendieck ◽  
Laura Prieto ◽  
Ana Chiesa ◽  
Sonia Bengolea ◽  
Graciela Bossi ◽  
...  
Keyword(s):  
Congenital Adrenal Hyperplasia ◽  
Neonatal Screening ◽  
Screening Program ◽  
Adrenal Hyperplasia ◽  
Recall Protocol ◽  
Neonatal Screening Program
Sign in / Sign up

Export Citation Format

Share Document